Parallel Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Parallel Advisors’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$605	–	3576
2023 Q1	$605	Hold	5	–	–	﹤0.01%	3063
2022 Q4	$574	Hold	5	–	–	﹤0.01%	3014
2022 Q3	$1K	Hold	5	–	–	﹤0.01%	3087
2022 Q2	$1K	Hold	5	–	–	﹤0.01%	2921
2022 Q1	$1K	Buy	+5	New	+$578	﹤0.01%	2902

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Parallel Advisors's BSX.PRA Position: Q2 2023 in Review

Parallel Advisors sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 5 shares — an estimated $605 sold.

Parallel Advisors first reported a position in BSX.PRA in Q1 2022 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Parallel Advisors reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Parallel Advisors sold 5 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $605.
Parallel Advisors first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q1 2022 and held it in 5 quarters.
Parallel Advisors's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $1K in Q3 2022.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Parallel Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.